Annual long term debt:
$428.19M-$140.41M(-24.69%)Summary
- As of today (September 17, 2025), PCRX annual long term debt is $428.19 million, with the most recent change of -$140.41 million (-24.69%) on December 31, 2024.
- During the last 3 years, PCRX annual long term debt has fallen by -$318.07 million (-42.62%).
- PCRX annual long term debt is now -42.62% below its all-time high of $746.26 million, reached on December 31, 2021.
Performance
PCRX Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$419.39M-$5.58M(-1.31%)Summary
- As of today (September 17, 2025), PCRX quarterly long term debt is $419.39 million, with the most recent change of -$5.58 million (-1.31%) on June 30, 2025.
- Over the past year, PCRX quarterly long term debt has dropped by -$220.06 million (-34.41%).
- PCRX quarterly long term debt is now -47.54% below its all-time high of $799.45 million, reached on March 31, 2022.
Performance
PCRX Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
PCRX Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.7% | -34.4% |
| 3 y3 years | -42.6% | -46.9% |
| 5 y5 years | +23.4% | +8.1% |
PCRX Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.6% | at low | -46.9% | at low |
| 5 y | 5-year | -42.6% | +23.4% | -47.5% | +9.2% |
| alltime | all time | -42.6% | >+9999.0% | -47.5% | >+9999.0% |
PCRX Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $419.39M(-1.3%) |
| Mar 2025 | - | $424.97M(-0.8%) |
| Dec 2024 | $428.19M(-24.7%) | $428.19M(-1.3%) |
| Sep 2024 | - | $433.77M(-32.2%) |
| Jun 2024 | - | $639.45M(+13.4%) |
| Mar 2024 | - | $564.13M(-0.8%) |
| Dec 2023 | $568.60M(-21.1%) | $568.60M(-0.8%) |
| Sep 2023 | - | $573.03M(-3.2%) |
| Jun 2023 | - | $592.23M(-2.2%) |
| Mar 2023 | - | $605.36M(-16.0%) |
| Dec 2022 | $720.63M(-3.4%) | $720.63M(-7.5%) |
| Sep 2022 | - | $779.40M(-1.3%) |
| Jun 2022 | - | $789.45M(-1.3%) |
| Mar 2022 | - | $799.45M(+7.1%) |
| Dec 2021 | $746.26M(+94.3%) | $746.26M(+89.9%) |
| Sep 2021 | - | $392.93M(+0.8%) |
| Jun 2021 | - | $389.94M(+0.8%) |
| Mar 2021 | - | $387.00M(+0.8%) |
| Dec 2020 | $384.06M(+10.7%) | $384.06M(-27.4%) |
| Sep 2020 | - | $528.91M(+36.3%) |
| Jun 2020 | - | $388.07M(+10.8%) |
| Mar 2020 | - | $350.27M(+0.9%) |
| Dec 2019 | $346.98M(+19.4%) | $346.98M(+1.8%) |
| Sep 2019 | - | $340.96M(+1.1%) |
| Jun 2019 | - | $337.23M(+4.2%) |
| Mar 2019 | - | $323.65M(+11.4%) |
| Dec 2018 | $290.59M(+5.2%) | $290.59M(+1.3%) |
| Sep 2018 | - | $286.89M(+1.3%) |
| Jun 2018 | - | $283.26M(+1.3%) |
| Mar 2018 | - | $279.69M(+1.3%) |
| Dec 2017 | $276.17M | $276.17M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $272.72M(+1.3%) |
| Jun 2017 | - | $269.33M(+1.3%) |
| Mar 2017 | - | $265.99M(+144.6%) |
| Dec 2016 | $108.74M(>+9900.0%) | $108.74M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $226.00K(-99.1%) | $226.00K(-43.9%) |
| Sep 2013 | - | $403.00K(-99.6%) |
| Jun 2013 | - | $97.48M(+0.9%) |
| Mar 2013 | - | $96.58M(+270.8%) |
| Dec 2012 | $26.05M(+29.8%) | $26.05M(+0.9%) |
| Sep 2012 | - | $25.81M(-0.5%) |
| Jun 2012 | - | $25.94M(+3.5%) |
| Mar 2012 | - | $25.07M(+24.9%) |
| Dec 2011 | $20.07M(-73.1%) | $20.07M(-10.6%) |
| Sep 2011 | - | $22.45M(-0.6%) |
| Jun 2011 | - | $22.58M(+0.6%) |
| Mar 2011 | - | $22.45M(-69.9%) |
| Dec 2010 | $74.66M(+189.2%) | $74.66M(+151.7%) |
| Sep 2010 | - | $29.66M(+427.3%) |
| Jun 2010 | - | $5.63M |
| Dec 2009 | $25.82M | - |
FAQ
- What is Pacira BioSciences, Inc. annual long term debt?
- What is the all time high annual long term debt for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual long term debt year-on-year change?
- What is Pacira BioSciences, Inc. quarterly long term debt?
- What is the all time high quarterly long term debt for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly long term debt year-on-year change?
What is Pacira BioSciences, Inc. annual long term debt?
The current annual long term debt of PCRX is $428.19M
What is the all time high annual long term debt for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual long term debt is $746.26M
What is Pacira BioSciences, Inc. annual long term debt year-on-year change?
Over the past year, PCRX annual long term debt has changed by -$140.41M (-24.69%)
What is Pacira BioSciences, Inc. quarterly long term debt?
The current quarterly long term debt of PCRX is $419.39M
What is the all time high quarterly long term debt for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly long term debt is $799.45M
What is Pacira BioSciences, Inc. quarterly long term debt year-on-year change?
Over the past year, PCRX quarterly long term debt has changed by -$220.06M (-34.41%)